Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Ann Plast Surg. 2020 Jun;84(6):S405–S410. doi: 10.1097/SAP.0000000000002285

Table 3:

Therapeutic mastectomies: Surgical indication and breast cancer stage.

Autologous Fat Grafting Status
Overall No AFG AFG p
Number of Mastectomies 277 204 73
Histology Type, n (%) 0.001
 Mixed IDC and ILC 8 (2.9) 8 (4.0) 0 (0.0)
 LCIS 1 (0.4) 1 (0.5) 0 (0.0)
 ILC 18 (6.6) 9 (4.5) 9 (12.3)
 IDC 177 (64.8) 138 (69.0) 39 (53.4)
 DCIS 56 (20.5) 40 (20.0) 16 (21.9)
 Unknown 13 (4.8) 4 (2.0) 9 (12.3)
Pathologic Stage, n (%) 0.038
 0 45 (16.5) 33 (16.5) 12 (16.4)
 1 88 (32.2) 72 (36.0) 16 (21.9)
 2 98 (35.9) 69 (24.5) 29 (39.7)
 3 18 (6.6) 14 (7.0) 4 (5.5)
 Unknown 24 (8.8) 12 (6.0) 12 (16.4)

Statistically significant, DCIS = ductal carcinoma in situ; IDC = invasive ductal carcinoma; ILC = invasive lobular carcinoma; LCIS = lobular carcinoma in situ.